ICD-10 N04.B2
Billable / Specific CCNephrotic syndrome with secondary immune complex membranoproliferative glomerulonephritis (IC-MPGN)
About ICD-10-CM N04.B2
ICD-10-CM code N04.B2 represents Nephrotic syndrome with secondary immune complex membranoproliferative glomerulonephritis (IC-MPGN). This is a billable/specific code in the Genitourinary System chapter (block N04). The 2026 edition of ICD-10-CM N04.B2 became effective on October 1, 2025.
Coding Tips for N04.B2
Specialist guidance from the PayerReady Medical Coding Team. Specificity warnings, HCC capture rules, sequencing notes.
N04.B2 is designated CC for MS-DRG grouping. On inpatient claims, this code can shift the DRG to the with-CC variant when documented as a present-on-admission secondary diagnosis. Hospital CDI programs flag CC opportunities during chart review. Failure to capture this code may leave 30 to 80 percent of the inpatient stay revenue unrealized.
Medicare Advantage HCC Impact
Capture this diagnosis annually for accurate risk adjustment. Missed HCC captures are the #1 revenue leak in Medicare Advantage risk programs.
Inpatient DRG Impact, CC
codes Nephrotic syndrome with secondary immune complex membranoproliferative glomerulonephritis (IC-MPGN). As a Complication/Comorbidity (CC), this contributes to DRG severity adjustment when documented alongside the principal diagnosis.
Medicare LCD Coverage for N04.B2
Local Coverage Determinations (LCDs) from CMS MACs that list N04.B2 as a covered diagnosis.
Showing top 4. Click a CPT for full coverage scope.
Commercial Payer Coverage
Coverage policies from major commercial payers referencing N04.B2.
2 Medicare
CPT Codes Commonly Billed with N04.B2
Procedures frequently paired with this diagnosis based on PayerReady's Dx↔Px linkage data.
- Q5152 CMS LCD: Billing and Coding: Eculizumab, and Biosimilars: EPYSQLI�-eculizumab-aagh, and BKEMV�-eculizumab-aeeb CMS LCD
- Q5151 CMS LCD: Billing and Coding: Eculizumab, and Biosimilars: EPYSQLI�-eculizumab-aagh, and BKEMV�-eculizumab-aeeb CMS LCD
- J1299 CMS LCD: Billing and Coding: Eculizumab, and Biosimilars: EPYSQLI�-eculizumab-aagh, and BKEMV�-eculizumab-aeeb CMS LCD
Codes Adjacent To N04.B2
Other codes in section N00-N08 (Glomerular diseases).
ICD-10 N04.B2, Billing FAQ
Is ICD-10 code N04.B2 billable? +
Yes, N04.B2 is a billable ICD-10-CM code that can appear as a primary or secondary diagnosis on claims.
Is N04.B2 a CC or MCC for inpatient DRG? +
Yes, this code is designated as CC. Documenting as a secondary diagnosis on inpatient claims can shift the DRG to a higher-weighted category.
What CPT codes are commonly billed with N04.B2? +
Procedures frequently paired with N04.B2 include: Q5152, Q5151, J1299.
Get the full PayerReady toolkit
Free access to CPT/ICD-10 lookup, denial appeals, fee comparator, and claim auditing with credentialing enrollment.
Start free →Run this code through our claim audit tool
Check NCCI bundling, MUE limits, and modifier logic before submission.
Try the auditor →Did this page help?
Quick signal so we know what to improve.
If you want a code reference page that doesn't exist yet, email coding@payerready.com.
Tell us what's missing or wrong: coding@payerready.com. We respond within 5 business days.
Reviewed by the PayerReady Medical Coding Team
Verified against the CMS 2026 code set on May 31, 2026.
Powered by 11K CPT · 98K ICD-10 · 860K MPFS rates · 4.5M NCCI edits · 9.5M NPIs. Our data methodology · About our coding team